Alaska Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Arena's Lorcaserin Expected To Be Approved
By: MarketMinute.com Stock News
Posted on June 18, 2012 at 17:25 PM EDT

According to TheStreet's FDA Drug Approval Contest, Arena Pharmaceuticals Inc.'s (Nasdaq: ARNA) Lorcaserin is expected to receive regulatory approval on June 27. Shares of the biopharmaceutical climbed 98 cents to close at $9.38.


Related Stocks:
Arena Pharmaceuticals, Inc.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here